TGFB1 and cancer: TGF-β1/TNF-α/Interferon (IFN)-γ-dependent activation of the indoleamine 2,3 dioxygenase (IDO) pathway in lung, liver, and breast cancer cell lines also drives EMT and confers immunomodulatory properties to the cells, which both contribute to metastasis and cancer progression [23].